Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid receptor isoforms in glucocorticoid-resistant lymphoid malignancies
ChiCTR-RCH-12002872Phase 4Completed
- Sponsor
- Department of Hematology, First Affiliated Hospital of Dalian Medical University
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisone in multiple myeloma (MM), acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) (6 arms), sponsored by Department of Hematology, First Affiliated Hospital of Dalian Medical University. Primary endpoints: Blood routine parameters and Glucocorticoid receptor isoform expression. Started Dec 2010; status: completed.
02
Drugs
prednisone
03
Conditions
multiple myeloma (MM)acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ChiCTR-RCH-12002872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RCH-12002872.